Evidence map›Paper›PMID 39280580›Full record

ArticleBioactive materials2024

Neuroprotection on ischemic brain injury by Mg

Yang Zhang, Hongkang Zhang, Miaowen Jiang, Xiaofeng Cao, Xiaoxiao Ge, Baoying Song, Jing Lan, Wenhao Zhou, Zhengfei Qi, Xuenan Gu and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioactive materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yang ZhangDepartment of Neurology and Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Hongkang ZhangSchool of Materials Science and Engineering, Peking University, Beijing, 100871, China.
Miaowen JiangBeijing Institute for Brain Disorders, Capital Medical University, Beijing, 100069, China.
Xiaofeng CaoSchool of Materials Science and Engineering, Peking University, Beijing, 100871, China.
Xiaoxiao GeBeijing Institute for Brain Disorders, Capital Medical University, Beijing, 100069, China.
Baoying SongDepartment of Neurology and Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Jing LanBeijing Institute for Brain Disorders, Capital Medical University, Beijing, 100069, China.
Wenhao ZhouBiomaterials Research Center, Northwest Institute for Non-ferrous Metal Research, Xi'an, 710016, China.
Zhengfei QiBeijing Institute for Brain Disorders, Capital Medical University, Beijing, 100069, China.
Xuenan GuSchool of Bioengineering, Beihang University, Beijing, 100191, China.
Juzhe LiuThe Key Laboratory of Resources and Environmental System Optimization, Ministry of Education, College of Environmental Science and Engineering, North China Electric Power University, Beijing, 100096, China.
Yufeng ZhengSchool of Materials Science and Engineering, Peking University, Beijing, 100871, China.
Ming LiDepartment of Neurology and Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Xunming JiDepartment of Neurology and Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most acute ischemic stroke patients with large vessel occlusion require stent implantation for complete recanalization. Yet, due to ischemia-reperfusion injury, over half of these patients still experience poor prognoses. Thus, neuroprotective treatment is imperative to alleviate the ischemic brain injury, and a proof-of-concept study was conducted on "biodegradable neuroprotective stent". This concept is premised on the hypothesis that locally released Mg

Indexed as

Acute ischemic strokeBiodegradable implantationHydrogenMagnesiumNeuroprotection

Identifiers

PMID39280580
PMCPMC11402188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.